Rua Bioscience Raises Approximately NZ$1 Million Through Rights Offer

Rua Bioscience confirmed on 20 October that its shareholder rights offer had raised approximately NZ$1 million at an issue price of NZ$0.025 per new share. The capital is intended to support the company’s growth and working-capital needs, providing a recent example of equity fundraising activity in New Zealand’s biotechnology sector.